The Society for Neuro-Oncology (SNO), the preeminent trade organization for those working in the brain tumor arena, seeks to advance the field through research and education. SNO hosts an annual multi-day meeting that is ‘must-go’ for brain cancer researchers, clinicians, surgeons, patient advocacy organizations, and biopharma industry executives
When The Cancer Genome Atlas (TCGA) launched in 2006, it was a huge moment for cancer research. The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) had come together to deliver researchers a better understanding of the molecular basis of cancer through the application of genome analysis and sequencing technologies.
National Brain Tumor Society launched our Defeat GBM Research Collaborative in March of 2013 to great enthusiasm from both the patient and scientific communities. As our boldest strategic research initiative to-date, the Defeat GBM Research Collaborative aims to double the five-year survival rate of glioblastoma multiforme (GBM) patients in just five years.